Merck's HPV vaccine shines in Phase III trials.
D004345:Drug Industry; D006801:Humans; D027383:Papillomaviridae / Q000276:immunology*; D030361:Papillomavirus Infections / Q000517:prevention & control*; D053918:Papillomavirus Vaccines; D014765:Viral Vaccines / Q000276:immunology*
D053918:Papillomavirus Vaccines; D014765:Viral Vaccines